Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis

ConclusionMyosteatosis is highly prevalent in patients with cirrhosis, particularly in those with NAFLD-associated cirrhosis. Myosteatosis is associated with hepatic encephalopathy, while it seems to have a negative impact on the outcome.
Source: Hepatology International - Category: Infectious Diseases Source Type: research